George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIND.L Regulatory News (IND)

  • There is currently no data for IND

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.5 (EPT/RI) IndigoVision Group

27 Mar 2020 09:34

RNS Number : 8588H
Nplus1 Singer Capital Markets Ltd
27 March 2020
 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Nplus1 Singer Capital Markets Limited

 

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

 

INDIGOVISION GROUP PLC ORD

 

(c) Name of the party to the offer with which exempt principal trader is connected:

 

INDIGOVISION GROUP PLC ORD

 

 

(d) Date dealing undertaken:

26 March 2020

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?

If it is a cash offer or possible cash offer, state "N/A"

NO

 

If YES, specify which:

 

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

 

ORD 1P

 

 

Purchase

 

625

 

375.51p

 

375.51p

 

ORD 1P

 

 

Sale

 

1,000

 

380p

 

380p

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

 

 

 

Date of disclosure:

27 March 2020

Contact name:

Sarah-Rose Perry, Jennifer Bentick, Nick Wright

Telephone number:

020 7496 3093

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
FERGCGDXGXDDGGR
Date   Source Headline
2nd May 201910:41 amRNSDirector/PDMR Shareholding
1st May 201912:00 pmRNSDirector/PDMR Shareholding
23rd Apr 20199:36 amRNSDirector/PDMR Shareholding
18th Apr 20195:19 pmRNS2018 Annual Report & Notice of AGM
29th Mar 20197:00 amRNSAppointment of Non-Executive Director
12th Mar 201911:45 amRNSDirector/PDMR Shareholding
11th Mar 20197:00 amRNSDirector/PDMR Shareholding
10th Jan 20197:00 amRNSTrading Statement
21st Nov 20183:45 pmRNSGrant of awards under the Company's 2018 LTIP
24th Oct 201810:25 amRNSResult of General Meeting
5th Oct 20187:00 amRNSPosting of Circular & Notice of General Meeting
4th Oct 20185:38 pmRNSHolding(s) in Company
20th Sep 20187:00 amRNSHalf-year Report
15th Aug 20187:00 amRNSHolding(s) in Company
29th Jun 20187:00 amRNSPDMR Shareholding
17th May 20182:49 pmRNSResult of AGM
17th May 20187:00 amRNSAGM Trading Update
25th Apr 20182:52 pmRNSDirector/PDMR Shareholding
24th Apr 20184:57 pmRNS2017 Annual Report
20th Mar 20183:57 pmRNSPDMR Shareholding
15th Mar 20183:01 pmRNSDirector Shareholding
12th Mar 20189:20 amRNSCancellation of Block Listing & TVR
9th Mar 20186:07 pmRNSHolding(s) in Company
9th Mar 20186:05 pmRNSHolding(s) in Company
8th Mar 20184:26 pmRNSHolding(s) in Company
7th Mar 20185:56 pmRNSHolding(s) in Company
5th Mar 20188:31 amRNSPDMR Shareholdings
1st Mar 20187:00 amRNSFinal Results
9th Jan 20187:00 amRNSAppointment of Chief Executive Officer
28th Dec 201712:55 pmRNSBlock listing Interim Review
30th Nov 20177:00 amRNSHolding(s) in Company
27th Nov 20175:00 pmRNSPDMR Shareholding
24th Nov 20172:08 pmRNSPDMR Shareholding
24th Nov 20172:07 pmRNSTransaction in Own Shares
24th Nov 20177:00 amRNSTrading update and Board changes
20th Oct 20172:51 pmRNSGrant of Options
16th Oct 20177:00 amRNSDirectorate Change
2nd Oct 20172:00 pmRNSPDMR Appointment
22nd Sep 20173:31 pmRNSDirectors Dealings
22nd Sep 20177:00 amRNSInterim Results
18th Aug 20171:30 pmRNSPDMR Shareholding
1st Aug 20177:00 amRNSBoard Change
21st Jun 20173:46 pmRNSHolding(s) in Company
20th Jun 20177:00 amRNSHolding(s) in Company
16th Jun 20177:00 amRNSTransaction in Own Shares
12th Jun 20177:00 amRNSTransaction in Own Shares
5th Jun 20177:00 amRNSDirector/PDMR Shareholding
1st Jun 20177:00 amRNSDirectorate Change
30th May 20177:00 amRNSDirectorate Change
23rd May 20177:00 amRNSShare Buyback Programme

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.